Viral DsRNA-activated Human Dendritic Cells Produce IL-27, Which Selectively Promotes Cytotoxicity in Naive CD8+ T Cells
Overview
Authors
Affiliations
Viral recognition programs DCs to express Signal 3 molecules that promote the differentiation of effector CD8(+) T cells. Besides IL-12, another DC-derived IL-12 family member, IL-27, has been reported to contribute herein, but its specific role is not well understood. Here, we show that whereas IL-12 potently induces inflammatory cytokines (i.e., IFN-γ and TNF-α, but not IL-2), IL-27 excels in inducing proliferation and a cytotoxic profile (GrB, cytotoxicity of target cells) in human naïve CD8(+) T cells. Compared with bacterial cell-wall peptidoglycan, viral dsRNA-mimic poly (I:C) is superior in priming human BDCA1(+) peripheral blood DCs to produce IL-12 and IL-27, which promote inflammatory cytokines and a cytotoxic profile in differentiating CD8(+) T cells, respectively. These data support the concept that viral dsRNA-activated human DCs produce IL-27 to act as a specialized procytotoxic, antiviral cytokine in the development of effector CD8(+) T cells.
An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases.
Xu W, Wang D, Zhao M, Huang A Front Immunol. 2024; 15:1366377.
PMID: 38566992 PMC: 10985211. DOI: 10.3389/fimmu.2024.1366377.
Crosstalk between TLR8 and RIG-I-like receptors enhances antiviral immune responses.
Vlaming K, van Wijnbergen K, Kaptein T, Nijhuis M, Kootstra N, de Bree G Front Med (Lausanne). 2023; 10:1146457.
PMID: 37261119 PMC: 10227620. DOI: 10.3389/fmed.2023.1146457.
Lo H, Yu D, Gao H, Tsai M, Chuang E Transl Cancer Res. 2022; 9(8):4618-4634.
PMID: 35117826 PMC: 8798123. DOI: 10.21037/tcr-20-1509.
Crosstalk between R848 and abortive HIV-1 RNA-induced signaling enhances antiviral immunity.
Stunnenberg M, van Hamme J, Zijlstra-Willems E, Gringhuis S, Geijtenbeek T J Leukoc Biol. 2022; 112(2):289-298.
PMID: 34982481 PMC: 9542596. DOI: 10.1002/JLB.4A0721-365R.
Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
Stunnenberg M, Sprokholt J, van Hamme J, Kaptein T, Zijlstra-Willems E, Gringhuis S Front Immunol. 2020; 11:8.
PMID: 32038656 PMC: 6990453. DOI: 10.3389/fimmu.2020.00008.